These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2719759)

  • 1. Plasma vitamin E, apolipoprotein B and HDL-cholesterol in middle-aged men from southern Italy.
    Rubba P; Mancini M; Fidanza F; Leccia G; Riemersma RA; Gey KF
    Atherosclerosis; 1989 May; 77(1):25-9. PubMed ID: 2719759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological variability in serum vitamin E concentrations: relation to serum lipids.
    Maes M; Weeckx S; Wauters A; Neels H; Scharpé S; Verkerk R; Demedts P; Desnyder R
    Clin Chem; 1996 Nov; 42(11):1824-31. PubMed ID: 8906083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced net mass transfer of HDL cholesteryl esters to Apo B-containing lipoproteins in patients with peripheral vascular disease.
    Rühling K; Zabel-Langhennig R; Till U; Thielmann K
    Clin Chim Acta; 1989 Oct; 184(3):289-96. PubMed ID: 2612001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B.
    Menys VC; Liu Y; Mackness MI; Caslake MJ; Kwok S; Durrington PN
    Clin Chim Acta; 2003 Aug; 334(1-2):95-106. PubMed ID: 12867279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian variation of postprandial lipemia.
    Romon M; Le Fur C; Lebel P; Edmé JL; Fruchart JC; Dallongeville J
    Am J Clin Nutr; 1997 Apr; 65(4):934-40. PubMed ID: 9094875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study.
    Brouwers MC; Troutt JS; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schaper NC; Schalkwijk CG; Konrad RJ; Stehouwer CD
    Atherosclerosis; 2011 Jul; 217(1):263-7. PubMed ID: 21497351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in plasma total and lipoprotein cholesterol during incubation of whole blood samples at 37 degrees C--influence of LCAT inhibitors.
    Rühling K; Lang A; Holtz H; Winkler L; Schlag B; Till U
    Clin Chim Acta; 1992 Feb; 205(3):205-12. PubMed ID: 1576746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial.
    Wu L; Piotrowski K; Rau T; Waldmann E; Broedl UC; Demmelmair H; Koletzko B; Stark RG; Nagel JM; Mantzoros CS; Parhofer KG
    Metabolism; 2014 Mar; 63(3):382-91. PubMed ID: 24360749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ; Brun D; Gagné C; Moorjani S; Bielman P; Julien P
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypobetalipoproteinemia associated with apo B-48.4, a truncated protein only 14 amino acids longer than apo B-48.
    Ruotolo G; Zanelli T; Tettamanti C; Ragogna F; Parlavecchia M; Viganò F; Catapano AL
    Atherosclerosis; 1998 Mar; 137(1):125-31. PubMed ID: 9568744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
    Sacks FM; Alaupovic P; Moye LA; Cole TG; Sussex B; Stampfer MJ; Pfeffer MA; Braunwald E
    Circulation; 2000 Oct; 102(16):1886-92. PubMed ID: 11034934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype.
    Luc G; Ducimetiere P; Bard JM; Arveiler D; Evans A; Cambien F; Fruchart JC; Fievet C
    Atherosclerosis; 1997 Jun; 131(2):257-62. PubMed ID: 9199280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased apolipoprotein B serum concentration in Alzheimer's disease.
    Caramelli P; Nitrini R; Maranhão R; Lourenço AC; Damasceno MC; Vinagre C; Caramelli B
    Acta Neurol Scand; 1999 Jul; 100(1):61-3. PubMed ID: 10416513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of serum apolipoprotein B and apolipoprotein A-1 and their ratio in healthy full term small for gestational age newborns.
    Agrawal A; Shrivastava J; Dwivedi R; Siddiqui M
    J Neonatal Perinatal Med; 2017; 10(1):49-53. PubMed ID: 28304324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.
    Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P
    Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin C supplementation on lipoprotein cholesterol, apolipoprotein, and triglyceride concentrations.
    Jacques PF; Sulsky SI; Perrone GE; Jenner J; Schaefer EJ
    Ann Epidemiol; 1995 Jan; 5(1):52-9. PubMed ID: 7728285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids and apolipoproteins in children with the Smith-Lemli-Opitz syndrome.
    Behúlová D; Bzdúch V; Skodová J; Dello Russo A; Corso G; Ponec J; Kasanická A
    J Inherit Metab Dis; 2000 Jun; 23(4):413-5. PubMed ID: 10896307
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered HDL particle in sickle cell disease: decreased cholesterol content is associated with hemolysis, whereas decreased Apolipoprotein A1 is linked to inflammation.
    Yalcinkaya A; Unal S; Oztas Y
    Lipids Health Dis; 2019 Dec; 18(1):225. PubMed ID: 31861992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.